Aspire Biopharma Holdings Inc Share Price

NASDAQ: ASBP

Small Cap

$0.45

+0.01

(+1.19%)

as on September 18, 2025 at 1:29 am IST

$₹

Aspire Biopharma Holdings Inc Stock Performance

as on September 18, 2025 at 1:29 am IST

Day's Low
Day's High
$0.44
Day's Price Range
$0.46
$0.45
2.22%
Downside
2.22%
Upside
52 Week's Low
52 Week's High
$0.22
52-Week Price Range
$9.86
$0.45
52.22%
Downside
2091.11%
Upside

Aspire Biopharma Holdings Inc share price movements today

Previous Close: $0.45
Open: $0.44
Volume: 647.9K
Day's Low - High: $0.44 - $0.46
52 Week Low - High: $0.22 - $9.86

Aspire Biopharma Holdings Inc Historical Returns

1 Month Return: -23.73 %
3 Month Return: + 41.55 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Aspire Biopharma Holdings Inc Stock Fundamentals & Key Indicators

Check Aspire Biopharma Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$20.2M

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

3326800.00%

Aspire Biopharma Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aspire Biopharma Holdings Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Aspire Biopharma Holdings Inc	NA	$20.2M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Aspire Biopharma Holdings Inc Stock's Interest Amongst Investors

Investment in Aspire Biopharma Holdings Inc Shares on INDmoney has grown by 2362.50% over the past 30 days, indicating increased transactional activity.

Time period: August 19, 2025 to September 18, 2025

Change:2362.50% versus previous 30 day period

Search interest for Aspire Biopharma Holdings Inc Stock has increased by 282% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:282% versus previous 30 day period

Aspire Biopharma Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-
Operating Income	0	0	0	0	0	0	0	-15	0
EBITDA	0	0	0	-	0	0	-8	-15	-1
Interest Expense	-	-	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	0	0	0	0	0	0	0	-15	-1
Income Tax Expense	-	-	0	-	-	0	0	-	-
Net Income	0	0	0	0	0	0	-11	-15	-1
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Aspire Biopharma Holdings Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-
Gross Profit	-	-	-
Operating Income	0	0	-1
EBITDA	0	0	-11
Interest Expense	-	0	0
Depreciation	-	-	-
Income Before Tax	0	0	-12
Income Tax Expense	0	0	0
Net Income	0	0	-12
Net Profit Margin	0.00%	0.00%	0.00%

Aspire Biopharma Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2024	Mar 2025	Jun 2025
Net Income	-8	-15	-1
Operating Cash Flow	0	-1	-1
Investing Cash Flow	-	-	-
Financing Cash Flow	0	3	-
Change in Cash	0	1	-1

Aspire Biopharma Holdings Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2023	Dec 2024
Net Income	0	-1
Operating Cash Flow	0	0
Investing Cash Flow	284	13
Financing Cash Flow	-284	-11
Change in Cash	0	0

Insights on Aspire Biopharma Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 207.0%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 164.5%
NEGATIVE IMPACT
Price Dip
In the last 1 month, ASBP stock has moved down by -23.7%

About Aspire Biopharma Holdings Inc

Aspire Biopharma Holdings, Inc. is an early-stage biopharmaceutical company. It develops and markets a technology for novel delivery mechanisms for FDA approved drugs, nutraceuticals, and supplements. It has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, and response time. Its Sublingual Aspirin Product, which addresses cardiology emergencies and pain management, is a granular or powder formulation of a soluble, Ph-neutral, fast-acting aspirin. It also has numerous pharmaceutical and nutraceutical applications under development in various areas, including but not limited to a Viagra/Cialis combination product which is faster acting, requiring decreased dosages with the benefit of a longer half-life, various bi-hormonal drugs such as testosterone, estrogen and weight loss drugs, and thyroid drugs, as well as various supplements including a rapid-absorbing pre-workout and a melatonin sleep aid.

Organisation	Aspire Biopharma Holdings Inc
Headquarters	23150 Fashion Drive, Estero, FL, United States, 33928
CEO	Mr. Kraig T. Higginson
E-voting on shares	Click here to vote

Key Management of Aspire Biopharma Holdings Inc

Name	Title
Mr. Kraig T. Higginson	Interim CEO, President & Executive Chairman of the Board
Mr. Ernest J. Scheidemann Jr.	Chief Financial Officer
Mr. Stephen E. Quesenberry	General Counsel & Corporate Secretary

FAQs

What is Aspire Biopharma Holdings Inc share price today?

Aspire Biopharma Holdings Inc share price today is $0.45 as on September 18, 2025 at 1:29 am IST at the close of the market. Aspire Biopharma Holdings Inc share today touched a day high of $0.46 and a low of $0.44.

What is the 52 week high and 52 week low for Aspire Biopharma Holdings Inc share?

Aspire Biopharma Holdings Inc share touched a 52 week high of $9.86 on February 20, 2025 and a 52 week low of $0.22 on May 23, 2025. Aspire Biopharma Holdings Inc stock price today i.e. September 18, 2025 at 1:29 am IST is closed at $0.45,which is 95.44% down from its 52 week high and 109.30% up from its 52 week low.

What is Aspire Biopharma Holdings Inc's market capitalisation today?

Aspire Biopharma Holdings Inc market capitalisation is $0.00T as on September 18, 2025 at 1:29 am IST.

How to invest in Aspire Biopharma Holdings Inc Stock (ASBP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Aspire Biopharma Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aspire Biopharma Holdings Inc Shares that will get you 3.3333 shares as per Aspire Biopharma Holdings Inc share price of $0.45 per share as on September 18, 2025 at 1:29 am IST.

What is the minimum amount required to buy Aspire Biopharma Holdings Inc Stock (ASBP) from India?

Indian investors can start investing in Aspire Biopharma Holdings Inc (ASBP) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 12:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Aspire Biopharma Holdings Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 12:40 pm IST). Based on Aspire Biopharma Holdings Inc share’s latest price of $0.45 as on September 18, 2025 at 1:29 am IST, you will get 22.2222 shares of Aspire Biopharma Holdings Inc. Learn more about fractional shares .